According to Nova One Advisor, the global cell expansion market size is calculated at USD 25.93 billion in 2025 and is expected to be hit around USD 77.08 billion by 2034, growing at a compound annual growth rate (CAGR) of 12.87% over the forecast period 2025 to 2034. A study published by Nova One Advisor a sister firm of Precedence Research.
Ottawa, Nov. 13, 2025 (GLOBE NEWSWIRE) — The global cell expansion market size is calculated at USD 22.97 billion in 2024, grows to USD 25.93 billion in 2025, and is projected to hit around USD 77.08 billion by 2034, registering a CAGR of 12.87% over the forecast period of 2025 to 2034. The market is growing due to rising demand for regenerative medicines, cell-based therapies, and biologics production. Advancements in stem cell research and biopharmaceutical manufacturing further accelerate market growth.
Key Takeaways
- North America dominated the cell expansion market with a revenue share in 2024.
- Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
- By product, the consumables segment held the largest market share in 2024.
- By product, the instruments segment is expected to grow at the fastest CAGR in the market during the forecast period.
- By cell type, the mammalian cells segment led the market in 2024.
- By cell type, the human stem cells segment is expected to grow at the fastest CAGR in the market during the forecast period.
- By end-use, the biotechnology segment dominated the market in 2024.
- By end-use, the research institutes segment is expected to grow at the fastest CAGR in the market during the forecast period.
- By application, the biopharmaceutical segment held the highest market share in 2024.
- By application, the vaccine production segment is expected to grow at the fastest CAGR in the market during the forecast period.
Download a Sample Report Here@ https://www.novaoneadvisor.com/report/sample/7985
What is Cell Expansion?
Cell expansion is the process of growing and multiplying cells in controlled conditions to produce large quantities for research, therapeutic, or biomanufacturing purposes. The market is growing due to increasing demand for regenerative medicine, cell-based therapies, and personalized treatments. The rising prevalence of chronic and genetic diseases is driving research on stem cells and immunotherapies. Advancements in bioreactor technologies, automation, and cell culture systems are enhancing scalability and efficiency. Additionally, growing investments in biopharmaceutical manufacturing and government support for cell therapy research are boosting market expansion across clinical, research, and commercial applications.
What are the Primary Growth Drivers of the Cell Expansion Market?
The major growth drivers of the market include rising demand for regenerative medicine and cell-based therapies, increasing prevalence of chronic and genetic diseases, and advancements in stem cell and bioprocessing technologies. Growing biopharmaceutical production, government funding for cell research, and technological innovations in automated cell culture systems further accelerate market expansion, supporting large-scale therapeutic and research applications.
What are the Key trends in the Cell Expansion Market in 2024?
- In February 2024, BioCentriq released public data on CAR-T cell expansion achieved using Terumo Blood and Cell Technologies’ Quantum Flex Cell Expansion System, showcasing its effectiveness in advanced cell therapy production.
- In February 2024, Multiply Labs and Thermo Fisher Scientific expanded their partnership to advance automation in cell therapy manufacturing, specifically improving cell expansion and separation processes for greater efficiency and scalability.
Immediate Delivery Available | Buy This Premium Research (Global Deep Dive USD 3800) https://www.novaoneadvisor.com/report/checkout/7985
Cell Expansion Market Report Scope
| Report Attribute | Details |
| Market size value in 2025 | USD 25.93 billion |
| Revenue forecast in 2034 | USD 77.08 billion |
| Growth rate | CAGR of 12.35% from 2025 to 2034 |
| Base year for estimation | 2024 |
| Historical data | 2018 – 2024 |
| Forecast period | 2025 – 2034 |
| Quantitative units | Revenue in USD million and CAGR from 2025 to 2034 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Product, Cell Type, Application, End-use, Region |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
| Key companies profiled | Thermon Fisher Scientific, Inc., Corning Incorporated, Merck KGaA, Molteni Biotec, BD (Becton, Dickinson and Company), Terumo BCT, Inc., Sartorius AG, Takara Bio Inc., TRINOVA BIOCHEM GmbH, oocyte technologies GmbH |
| Customization scope | Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
For more information, visit the Nova One Advisor website or email the team at [email protected] | Call us : +1 804 420 9370
What are the Emerging Challenges in the Cell Expansion Market?
The emerging challenge in the market is achieving consistent cell quality and scalability while maintaining cost efficiency. Large-scale production often faces issues like contamination risk, variability in cell growth, and complex process control. Additionally, the need for advanced bioreactor technologies, skilled personnel, and regulatory compliance adds to the complexity, making it difficult to standardize and streamline cell therapy manufacturing processes.
Segmental Insights
By Product Insights
How did the Consumables Segment Dominate the Cell Expansion Market in 2024?
In 2024, the consumables segment held the largest market share due to the high recurring demand for products such as media, reagents, sera, and growth supplements used in every cell culture process. These materials are essential for maintaining cell viability, growth, and expansion across research and clinical applications. Additionally, increasing cell therapy production, biopharmaceutical manufacturing, and ongoing R&D activities further boosted the frequent use and dominance of consumables in the market.
- For Instance, In May 2023, Lonza launched the TheraPEAK T-VIVO Cell Culture Medium, a chemically defined, animal-free solution designed to improve CAR T-cell production. The medium enhances consistency, simplifies regulatory processes, and supports faster cell therapy development.
The instruments segment is expected to grow at the fastest CAGR due to rising adoption of advanced bioreactors, automated cell expansion systems, and cell counters that enhance efficiency, scalability, and precision in cell culture processes. Increasing demand for automation in cell therapy manufacturing, coupled with technological advancements in monitoring and control systems, is driving this growth. Additionally, the push for standardized, large-scale production of high-quality cells further fuels demand for innovative instruments.
By Cell Type Insights
What made the Mammalian cells Segment Dominant in the Cell Expansion Market in 2024?
In 2024, the mammalian cells segment dominated the market due to its extensive use in producing complex biopharmaceuticals, including monoclonal antibodies, vaccines, and recombinant proteins. Mammalian cells closely resemble human cells, enabling accurate protein expression and post-translational modifications essential for therapeutic development. Their growing application in regenerative medicine and cell-based therapies, along with advancements in culture techniques, further strengthened their dominance in the cell expansion market.
The human stem cells segment is projected to grow at the fastest CAGR due to their vital role in regenerative medicine, tissue engineering, and personalized therapies. Rising research in stem cell-based treatment for chronic and genetic diseases, along with advancements in culture and differentiation techniques, is fueling demand. Additionally, increased investments in stem cell research, expanding clinical applications, and supportive government initiatives are driving rapid growth in the market.
By End User Insights
Why the Biotechnology Segment Dominated the Cell Expansion Market in 2024?
In 2024, the biotechnology segment dominated the market due to its extensive use of cell expansion technologies in drug discovery, biopharmaceutical production, and cell-based research. Growing demand for biologics, including monoclonal antibodies and vaccines, has increased reliance on efficient cell culture systems. Additionally, continuous R&D investments, advancement in bioprocessing technologies, and the rising adoption of automation in biotechnology companies further strengthened this segment’s leading position in the cell expansion market.
The research institutes segment is expected to grow at the fastest CAGR due to increasing academic and government-funded studies focused on stem cell research, regenerative medicine, and cell-based therapies. Rising collaboration between research organizations and biotech companies are driving innovation in cell culture and expansion technologies. Additionally, advancements in cell biology, growing interest in personalized medicine, and improved access to modern laboratory infrastructure are further supporting the rapid growth of this segment during the forecast period.
By Application Insights
What Made the Biopharmaceutical Segment Dominant in the Cell Expansion Market in 2024?
In 2024, the biopharmaceutical segment held the highest market share due to the growing demand fie biologics, including monoclonal antibodies, vaccines, and recombinant proteins. Cell expansion is a crucial step in producing these complex molecules on a large scale with high quality and consistency. Additionally, increased investments in biopharmaceutical manufacturing, advancements in cell culture technologies, and the rising prevalence of chronic diseases further strengthened this market dominance.
The Vaccine production segment is projected to grow at the fastest CAGR due to rising demand for effective vaccines against infectious and emerging diseases. Cell-based vaccine manufacturing offers higher efficiency, safety, and scalability compared to traditional methods. Ongoing advancements in cell culture technologies, increased government and private investments, and the need for rapid vaccine development during outbreaks are further driving the growth of this segment throughout the forecast period.
By Regional Analysis
How is North America contributing to the Expansion of the Cell Expansion Market?
In 2024, North America dominated the market due to strong presence of leading biopharmaceutical companies, advanced healthcare infrastructure, and significant investment in cell-based research. The region’s high adoption of regenerative medicine and cell therapies, coupled with supportive government initiatives and funding for R&D, further fueled growth. Additionally, technological advancements in bioprocessing and the rising prevalence of chronic diseases strengthened North America’s leadership in the global cell expansion market.
How is Asia-Pacific Accelerating the Cell Expansion Market?
The Asia-Pacific region is anticipated to grow at the fastest CAGR due to expanding biopharmaceutical and biotechnology industries, rising healthcare investments, and growing government support for stem cell and regenerative medicine research. Increasing demand for advanced therapies, availability of skilled researchers, and cost-effective manufacturing capabilities are attracting global companies to the region. Additionally, improving healthcare infrastructure and rising prevalence of chronic diseases are further driving rapid growth in the Asia-Pacific cell expansion market.
Top Companies in the Cell Expansion Market
- Thermo Fisher Scientific, Inc.
- Corning Incorporated
- Merck KGaA
- Miltenyi Biotec
- BD (Becton, Dickinson and Company)
- Terumo BCT, Inc.
- Sartorius AG
- Takara Bio Inc.
- TRINOVA BIOCHEM GmbH
- upcyte technologies GmbH
Recent Developments in the Cell Expansion Market
- In June 2024, Cytiva introduced the Sefia next-generation manufacturing platform to help drug developers and healthcare providers speed up CAR T-cell and other cell-based therapy production while reducing overall manufacturing costs.
- In July 2024, Calidi Biotherapeutics, a clinical-stage biotech firm, received a USD 2 million investment from Dr. Ronald Rigor for its new subsidiary, Nova Cell, to advance its Adult Adipose Allogeneic (AAA) stem cell programs.
More Insights in Nova One Advisor:
- U.S. Livestock Monitoring Market – The U.S. livestock monitoring market size is estimated at USD 1.35 billion in 2024 and is anticipated to reach around USD 4.13 billion by 2034, expanding at a CAGR of 11.83% from 2024 to 2034.
- In Vitro Fertilization (IVF) Services Market – The global in vitro fertilization (IVF) services market size was estimated at USD 28.55 billion in 2024 and is expected to reach USD 66.30 billion in 2034, expanding at a CAGR of 8.79% during the forecast period of 2025 and 2034.
- Life Sciences IT Market – The global life sciences IT market size was estimated at USD 25.45 billion in 2024 and is expected to hit USD 69.01 billion in 2034, expanding at a CAGR of 10.49% over the forecast period of 2025-2034.
- U.S. Humidifiers Market – The U.S. humidifiers market size was estimated at USD 2.15 billion in 2024 and is projected to reach USD 4.54 billion by 2034, growing at a CAGR of 7.77% from 2025 to 2034.
- Digital Manufacturing in Life Sciences Market – The global digital manufacturing in life sciences market size was estimated at USD 36.0 billion in 2024, and it is expected to surpass around USD 153.3 billion by 2034, poised to grow at a CAGR of 15.59% from 2025 to 2034.
- Middle East AI In Patient Engagement Market – The Middle East patient engagement solutions market size was estimated at USD 183.75 million in 2024 and is expected to reach USD 1,373.35 million in 2034, expanding at a CAGR of 22.28% during the forecast period of 2025 and 2034.
- Middle East Cosmetic Surgery & Procedure Market – The Middle East cosmetic surgery and procedure market size was estimated at USD 2.15 billion in 2024 and is expected to reach USD 5.28 billion by 2034, growing at a CAGR of 9.41% from 2025 to 2034.
- Full Service CRO Market – The global full service CRO market size was estimated at USD 43.75 billion in 2024 and is expected to reach USD 89.67 billion in 2034, growing at a CAGR of 7.44% during 2025-2034.
- CRISPR Technology Market – The global CRISPR technology market size is calculated at USD 6.25 billion in 2024, grew to USD 7.29 billion in 2025, and is projected to reach around USD 28.93 billion by 2034. The market is expanding at a CAGR of 16.56% between 2025 and 2034.
- Pet Insurance Market – The global pet insurance market size was valued at USD 19.15 billion in 2024, and is predicted to be worth around USD 96.63 billion by 2034, registering a CAGR of 17.57% during the forecast period 2025 to 2034.
- Rotator Cuff Repair Market – The global rotator cuff repair market size was estimated at USD 899.85 million in 2024 and is expected to hit USD 1,870.20 million by 2034, expanding at a CAGR of 7.59% during the forecast period from 2025 to 2034.
- Animal Pregnancy Test Kit Market – The global animal pregnancy test kit market size was estimated at USD 54.35 million in 2024 and is projected to reach USD 83.76 million by 2034, growing at a CAGR of 4.42% from 2025 to 2034.
- Life Science Cloud Market – The global life science cloud market size was estimated at USD 25.65 billion in 2024 and is projected to hit USD 106.05 billion in 2034, growing at a CAGR of 15.25% during 2025-2034.
- CRISPR-based Gene Editing Market – The global CRISPR-based gene editing market size was valued at USD 6.15 billion in 2024 and is anticipated to reach around USD 24.37 billion by 2034, growing at a CAGR of 14.76% from 2025 to 2034.
- Advanced Therapy Medicinal Products CDMO Market – The global advanced therapy medicinal products CDMO market size was estimated at USD 7.45 billion in 2024 and is projected to hit around USD 42.25 billion by 2034, growing at a CAGR of 18.95% during the forecast period from 2025 to 2034.
Cell Expansion Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the cell expansion market.
By Product
- Consumables
- Reagents, Media, & Serum
- Other Consumables
- Culture Flasks and Accessories
- Tissue Culture Flasks
- Bioreactor Accessories
- Other Culture Flasks and Accessories
- Instruments
- Automated Cell Expansion Systems
- Cell Counters
- Centrifuges
- Bioreactors
- Other Instruments
By Cell Type
- Mammalian
- Human
- Stem Cells (SCs)
- Adult SCs
- Embryonic SCs
- Induced Pluripotent SCs
- Differentiated Cells
- Stem Cells (SCs)
- Animal
- Human
- Microbial
- Others
By Application
- Biopharmaceuticals
- Tissue Culture & Engineering
- Vaccine Production
- Drug Development
- Gene Therapy
- Cancer Research
- Stem Cell Research
- Others
By End-use
- Biopharmaceutical & Biotechnology Companies
- Research Institutes
- Cell Banks
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Immediate Delivery Available | Buy This Premium Research Report (Global Deep Dive USD 3800) https://www.novaoneadvisor.com/report/checkout/7985
About-Us
Nova One Advisor is a global leader in market intelligence and strategic consulting, committed to delivering deep, data-driven insights that power innovation and transformation across industries. With a sharp focus on the evolving landscape of life sciences, we specialize in navigating the complexities of cell and gene therapy, drug development, and the oncology market, enabling our clients to lead in some of the most revolutionary and high-impact areas of healthcare.
Our expertise spans the entire biotech and pharmaceutical value chain, empowering startups, global enterprises, investors, and research institutions that are pioneering the next generation of therapies in regenerative medicine, oncology, and precision medicine.
Our Trusted Data Partners
Towards Chemical and Materials | Precedence Research | Statifacts | Towards Packaging | Towards Healthcare | Towards Food and Beverages | Towards Automotive | Towards Consumer Goods | Nova One Advisor | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics | Towards Chem and Material
Web: https://www.novaoneadvisor.com/
Contact Us
USA: +1 804 420 9370
Email: [email protected]
For Latest Update Follow Us: LinkedIn
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. NewIndiaObserver.com takes no editorial responsibility for the same.